EXELIOM
Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies. Exeliom develops a new class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system. The company was founded in 2016 and is headquartered in Dijon, France.
EXELIOM
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Dijon, Bourgogne, France
Country:
France
Website Url:
http://www.nextbiotix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7 M EUR
Technology used in webpage:
Google Apps For Business Microsoft Azure DNS Wix Wix DNS
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
INRA
INRA investment in Series A - Exeliom
Sofimac Innovation
Sofimac Innovation investment in Series A - Exeliom
Cap Innov'Est
Cap Innov'Est investment in Series A - Exeliom
Biocodex
Biocodex investment in Series A - Exeliom
Auriga Partners
Auriga Partners investment in Series A - Exeliom
Official Site Inspections
http://www.nextbiotix.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
